Amneal Pharmaceuticals to Present at Upcoming Investor Conferences

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that members of management will participate at the following upcoming investor conferences:

  • Goldman Sachs 40th Annual Global Healthcare Conference at 2:00 p.m. PT (5:00 p.m. ET) on June 12, 2019 in Rancho Palos Verdes, CA.
  • Raymond James Life Sciences & MedTech Conference at 3:00 p.m. ET on June 19, 2019 in New York, NY.

To access a live webcast of the presentation, visit Amneals Investor Relations Web site at https://investors.amneal.com.

The Goldman Sachs Conference webcast can also be accessed at the following URL: https://event.webcasts.com/starthere.jsp?ei=1249194&tp_key=29cffed06b&tp_special=8.

The Raymond James Conference webcast can also be accessed at the following URL: http://wsw.com/webcast/rj115/amrx/.

An archived version will be available approximately one hour after the live presentation and can be accessed at the same location for 90 days.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has approximately 6,000 employees in its operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty segment focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.

ALSO READ:   IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Natural Health Trends Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Mark Donohue
(908) 409-6718